MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Ngar Yee Louie Purchases 19,665 Shares of Stock

MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Ngar Yee Louie bought 19,665 shares of the business’s stock in a transaction dated Thursday, April 25th. The stock was bought at an average price of $2.03 per share, for a total transaction of $39,919.95. Following the purchase, the director now owns 1,167,189 shares in the company, valued at approximately $2,369,393.67. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

MAIA Biotechnology Stock Performance

Shares of MAIA opened at $2.94 on Friday. MAIA Biotechnology, Inc. has a 52 week low of $0.82 and a 52 week high of $3.07.

MAIA Biotechnology (NYSEAMERICAN:MAIA) last posted its quarterly earnings results on Thursday, March 21st. The company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.06). As a group, equities research analysts anticipate that MAIA Biotechnology, Inc. will post -1.25 EPS for the current year.

About MAIA Biotechnology

MAIA Biotechnology, Inc, a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer.